IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,048,537 | +579.8% | 84,198 | +498.2% | 0.01% | +450.0% |
| Q4 2022 | $301,346 | -96.1% | 14,075 | -96.7% | 0.00% | -96.0% |
| Q3 2022 | $7,656,000 | +131.3% | 426,750 | +24.0% | 0.05% | +150.0% |
| Q2 2022 | $3,310,000 | -24.9% | 344,106 | +31.3% | 0.02% | -9.1% |
| Q1 2022 | $4,410,000 | +3.8% | 262,014 | +3.1% | 0.02% | +4.8% |
| Q4 2021 | $4,249,000 | +96.4% | 254,129 | -40.1% | 0.02% | +40.0% |
| Q2 2020 | $2,163,000 | -1.1% | 424,138 | -33.3% | 0.02% | -25.0% |
| Q1 2020 | $2,188,000 | -63.1% | 636,119 | -7.9% | 0.02% | -51.2% |
| Q4 2019 | $5,927,000 | +582.8% | 690,794 | -10.9% | 0.04% | +583.3% |
| Q3 2019 | $868,000 | -23.1% | 775,259 | -10.8% | 0.01% | -14.3% |
| Q2 2019 | $1,129,000 | – | 868,659 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |